U.S. Markets closed

Chemotherapy Induced Nausea and Vomiting (CINV) - Epidemiology Insights - 2023

NEW YORK, April 4, 2017 /PRNewswire/ -- DelveInsight's "Chemotherapy Induced Nausea and Vomiting (CINV)- Epidemiology Insights-2023" Report provides an overview of the disease, historical and forecasted epidemiological data for the Incident cases of Chemotherapy Induced Nausea and Vomiting (CINV) from 2013-2023 for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan.


Read the full report: http://www.reportlinker.com/p04807888/Chemotherapy-Induced-Nausea-and-Vomiting-CINV-Epidemiology-Insights.html



Chemotherapy-induced nausea and vomiting (CINV) are both severe side effects of cancer treatment. CINV is a condition which makes a patient uncomfortable and has to be dealt properly as many patients delay their chemotherapy cycles or even refuse further treatment due to fear from future nausea and vomiting. Also, due to nausea and vomiting induced by chemotherapy, patients can't get nutrition properly and lose their energy and may become weak which may hinder the further chemotherapy cycles as patient wouldn't be physically string to bear the chemotherapy side-effects.

According to DelveInsight, the Incident cases Chemotherapy Induced Nausea and Vomiting (CINV) is increasing and is expected to be 2, 79,634 by 2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.


Scope
The report will help in developing business strategies by understanding the trends shaping and driving the Chemotherapy Induced Nausea and Vomiting (CINV) market.
Insightful review of the key market drivers and barriers.
To understand the regulatory scenario in major markets.
The Report covers the detailed historical and forecasted Chemotherapy Induced Nausea and Vomiting (CINV) epidemiology cases covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
Read the full report: http://www.reportlinker.com/p04807888/Chemotherapy-Induced-Nausea-and-Vomiting-CINV-Epidemiology-Insights.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/chemotherapy-induced-nausea-and-vomiting-cinv---epidemiology-insights---2023-300434703.html